| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.083 | 0.05 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.06 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.06 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.07 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.067 | 0.07 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.07 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.07 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.069 | 0.07 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | 0.069 | 0.07 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.069 | 0.08 |